First Manhattan’s Journey Medical DERM Stock Holding History

First Manhattan’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,294	Closed	-$56.1K	–	1506
2023 Q2	$56.1K	Hold	35,294	–	–	﹤0.01%	862
2023 Q1	$55.4K	Hold	35,294	–	–	﹤0.01%	899
2022 Q4	$67.8K	Hold	35,294	–	–	﹤0.01%	886
2022 Q3	$86K	Buy	+35,294	New	+$120K	﹤0.01%	844

Other funds holding DERM

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Manhattan's DERM Position: Q3 2023 in Review

First Manhattan sold out of Journey Medical (DERM) in Q3 2023, closing a stake of 35,294 shares — an estimated $56.1K sold.

First Manhattan first reported a position in DERM in Q3 2022 and held it in 4 quarters. The position peaked at $86K in Q3 2022. 21 funds tracked by Wall St. Rank hold DERM as of Q3 2023.

First Manhattan reported no remaining Journey Medical position as of Q3 2023 after selling out during the quarter.
First Manhattan sold 35,294 Journey Medical shares in Q3 2023, an estimated $56.1K.
First Manhattan first reported a position in Journey Medical in Q3 2022 and held it in 4 quarters.
First Manhattan's Journey Medical position peaked at $86K in Q3 2022.
21 funds tracked by Wall St. Rank held Journey Medical as of Q3 2023.

Based on First Manhattan's 13F filing for Q3 2023, filed 14 Nov 2023.